Profile
Kenneth A. Bauer has been a Director of GTC Biotherapeutics, Inc. since December 2004, Director of Thrombosis Clinical Research for the Beth Israel Deaconess Medical Center since 1997 and Professor of Medicine at the Harvard Medical School since 2004.
Dr. Bauer has been a Faculty Member of the Harvard Medical School since 1982.
He is Chairman of Council for the International Society on Thrombosis and Haemostasis.
He received a BS and an MS from the Massachusetts Institute of Technology and his Medical Education from the Stanford University School of Medicine.
He completed subspecialty training in medical oncology and hematology at the Dana Farber Cancer Institute and Beth Israel Hospital in Boston.
Kenneth A. Bauer active positions
| Companies | Position | Start |
|---|---|---|
The International Society of Thrombosis & Hemostasis | Corporate Officer/Principal | - |
Former positions of Kenneth A. Bauer
| Companies | Position | End |
|---|---|---|
| REVO BIOLOGICS INC | Director/Board Member | 2009-09-30 |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Corporate Officer/Principal | - |
Training of Kenneth A. Bauer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
The International Society of Thrombosis & Hemostasis | |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
- Stock Market
- Insiders
- Kenneth A. Bauer
















